Expert Outlook: Arcturus Therapeutics Through The Eyes Of 5 Analysts
2/7 23:00
5 analysts have expressed a variety of opinions on Arcturus Therapeutics (NASDAQ:ARCT) over the past quarter, offering a diverse set of opinions from bullish to bearish. The table below summarizes their recent ratings, showcasing the evolving sentiments within the past......